The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment

Current Eye Research

Volumn 39, Issue 1, 2014, Pages 21-30

  Jirsova, Katerina ^a   Brejchova, Kristyna ^a   Krabcova, Ivana ^a   Filipec, Martin ^b   Al Fakih, Aref ^a   Palos, Michalis ^c   Vesela, Viera ^a  

^a Charles University in Prague and General University Hospital in Prague   (Czech Republic)

^b European Eye Clinic Lexum   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Autologous serum; Dry eye disease; Epithelial cell density; Goblet cell density; Squamous metaplasia

Indexed keywords

ARTIFICIAL TEAR; AUTOLOGOUS SERUM EYE DROPS; BENZALKONIUM CHLORIDE; CELLULOSE ACETATE; CETRIMIDE; EYE DROPS; FLUORESCEIN; HLA DR ANTIGEN; HYALURONIC ACID; HYLO COMOD; HYPOTEARS; HYPOTEARS PLUS SDU; LACRISYN; MUCIN 1; MUCIN 2; MUCIN 3; POLIDRONIUM CHLORIDE; RECUGEL; REFRESH; ROSE BENGAL; TEARS NATURALE; TEARS NATURALE FREE; TEARS NATURALE II; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DENSITY; CHROMATIN; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; CONJUNCTIVA; CONTROLLED STUDY; DRY EYE; EPITHELIUM CELL; FEMALE; GOBLET CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMPRESSION CYTOLOGY; KERATINIZATION; LABORATORY TEST; MALE; NICK END LABELING; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PERIODIC ACID SCHIFF STAIN; PHOTOPHOBIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHIRMER TEST; SNAKE LIKE CHROMATIN; SQUAMOUS CELL METAPLASIA; TEAR FILM; TEAR FILM BREAKUP TIME; TEAR FILM DEBRIS; TEAR FILM MENISCUS; TREATMENT DURATION; VISUAL ACUITY; VISUAL ACUITY CHART; VISUAL SYSTEM PARAMETERS; VITAL STAIN;

ADULT; AGED; DRY EYE SYNDROMES; EPITHELIUM, CORNEAL; FEMALE; GOBLET CELLS; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VISION TESTS; VISUAL ACUITY;

EID: 84890374213     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.824987     Document Type: Article

References (50)

1. Methodologies to diagnose and monitor dry eye disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:108-152
2. McGinnigle S, Naroo SA, Eperjesi F. Evaluation of dry eye. Surv Ophthalmol 2012;57:293-316
3. Lemp MA. Advances in understanding and managing dry eye disease. Am J Ophthalmol 2008;146:350-356
4. Barabino S, Chen Y, Chauhan S, Dana R. Ocular surface immunity: Homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res 2012;31:271-285
5. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-4301
6. Nelson JD, Wright JC. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 1984;102: 1049-1051
7. Pflugfelder SC, Solomon A, Stern ME. The diagnosis and management of dry eye: A twenty-five-year review. Cornea 2000;19:644-649
8. Tseng SC. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985;92:728-733
9. Management and therapy of dry eye disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:163-178
10. Lemp MA. Management of dry eye disease. Am J Manag Care 2008;14:S88-101
11. Sahli E, Hosal BM, Zilelioglu G, Gulbahce R, Ustun H. The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye. Cornea 2010;29:1412-1416
12. Wang J, Cui L, Shen M, Perez VL, Wang MR. Ultra-high resolution optical coherence tomography for monitoring tear meniscus volume in dry eye after topical cyclosporine treatment. Clin Ophthalmol 2012;6:933-938
13. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: A prospective randomized case-control study. Am J Ophthalmol 2005; 139:242-246
14. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graftversus-host disease. Bone Marrow Transpl 2003;31: 579-583
15. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: Clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85:1188-1197
16. Na KS, Kim MS. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versushost disease. J Ocul Pharmacol Ther 2012;28:479-483
17. Young AL, Cheng AC, Ng HK, Cheng LL, Leung GY, Lam DS. The use of autologous serum tears in persistent corneal epithelial defects. Eye (Lond). 2004;18:609-614
18. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 2001;20:807-810
19. Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111: 1115-1120
20. Sharma N, Goel M, Velpandian T, Titiyal JS, Tandon R, Vajpayee RB. Evaluation of umbilical cord serum therapy in acute ocular chemical burns. Invest Ophthalmol Vis Sci 2011;52:1087-1092
21. del Castillo JM, de la Casa JM, Sardina RC, Fernandez RM, Feijoo JG, Gomez AC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002; 21:781-783
22. Chen YM, Hu FR, Huang JY, Shen EP, Tsai TY, Chen WL. The effect of topical autologous serum on graft reepithelialization after penetrating keratoplasty. Am J Ophthalmol 2010;150:352-359
23. Noda-Tsuruya T, Asano-Kato N, Toda I, Tsubota K. Autologous serum eye drops for dry eye after LASIK. J Refract Surg 2006;22:61-66
24. Bradley JC, Simoni J, Bradley RH, McCartney DL, Brown SM. Time-And temperature-dependent stability of growth factor peptides in human autologous serum eye drops. Cornea 2009;28:200-205
25. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467-1474
26. Jirsova K, Hrdlickova E, Alfakih A, Juklova K, Filipec M, Faltus V, et al. [The application of the autologous serum eye drops results in significant improvement of the conjunctival status in patients with the dry eye syndrome]. Cesk Slov Oftalmol 2008;64:52-56
27. Perry HD. Dry eye disease: Pathophysiology, classification, and diagnosis. Am J Manag Care 2008;14:S79-S87
28. Kasper K, Kremling C, Geerling G. [Toxicity of a new moistening agent and preservative in vitro]. Ophthalmologe 2008;105:557-562
29. Schrage N, Frentz M, Spoeler F. The Ex Vivo Eye Irritation Test (EVEIT) in evaluation of artificial tears: Puritepreserved versus unpreserved eye drops. Graefes Arch Clin Exp Ophthalmol 2012;250:1333-1340
30. Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea 2001;20:802-806
31. Papas EB, Vajdic CM. Inter-ocular characteristics of the pre-contact lens tear film. Curr Eye Res 2000;20:248-250
32. Nguyen P, Huang D, Li Y, Sadda SR, Ramos S, Pappuru RR, et al. Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease. Cornea 2012; 31:680-685
33. Feenstra RP, Tseng SC. Comparison of fluorescein and rose bengal staining. Ophthalmology 1992;99:605-617
34. Nelson JD, Havener VR, Cameron JD. Cellulose acetate impressions of the ocular surface. Dry eye states. Arch Ophthalmol 1983;101:1869-1872
35. Jirsova K, Juklova K, Vesela V, Filipec M. Morphological and immunocytochemical characterization of snake-like chromatin cells. Histol Histopathol 2006;21:355-360
36. Jirsova K, Juklova K, Alfakih A, Filipec M. Presence of snake-like chromatin in epithelial cells of keratoconjunctivitis sicca followed by a large number of micronuclei. Acta Cytol 2007;51:541-546
37. Jirsova K, Mandys V. Induction of micronuclei and granular chromatin condensation in human skin fibroblasts influenced by cisplatin (cis-DDP) in vitro. Mutat Res 1994; 310:37-44
38. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
39. Al-Fakih A, Faltus V, Jirsova K. A decrease in the density of HLA-DR-positive cells occurs faster in corneas stored in organ culture than under hypothermic conditions. Ophthalmic Res 2012;47:39-46
40. Konttinen YT, Li TF, Michelsson O, Xu JW, Sorsa T, Santavirta S, et al. Expression of tenascin-C in aseptic loosening of total hip replacement. Ann Rheum Dis 1998; 57:619-623
41. Yoon KC, Heo H, Im SK, You IC, Kim YH, Park YG. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol 2007;144:86-92
42. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647-652
43. Inatomi T, Spurr-Michaud S, Tisdale AS, Zhan Q, Feldman ST, Gipson IK. Expression of secretory mucin genes by human conjunctival epithelia. Invest Ophthalmol Vis Sci 1996;37:1684-1692
44. Brignole F, De Saint-Jean M, Goldschild M, Becquet F, Goguel A, Baudouin C. Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res 1998;67:687-697
45. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci 2000;41: 1356-1363
46. Luo L, Li DQ, Pflugfelder SC. Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 2007;26: 452-460
47. Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K. Autologous serum eye drops for the treatment of dry eye diseases. Cornea 2008;27: S25-S30
48. Shimmura S, Ueno R, Matsumoto Y, Goto E, Higuchi A, Shimazaki J, et al. Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol 2003;87: 1279-1283
49. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjogren's syndrome: Cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci 1994;35:3493-3504
50. Rolando M, Barabino S, Mingari C, Moretti S, Giuffrida S, Calabria G. Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea 2005;24:951-954